The Middle EAST Biopharmaceutical CMO and CRO Market was valued at USD 5.2 billion in 2024 and is projected to reach USD 12.3 billion by 2034, registering a CAGR of 8.9%. This growth trajectory is underpinned by several factors, including increasing investments in biopharmaceutical research and development, a rising demand for outsourcing services, and the growing prevalence of chronic diseases...